Dexcom stock closed at USD 84.53 on the Nasdaq on September 8, 2026, down 3.8 percent. The move left the shares 17.3 percent ...
Wells Fargo 21st Annual Healthcare Conference September 9, 2026 8:00 AM EDTCompany ParticipantsJereme Sylvain - Executive VP, CFO ...
Diabetics Trust, a nationwide buyer of unused diabetic supplies, reports that a growing share of the people using its buyback ...
The medtech industry is awaiting FDA guidance on generative AI. The agency has sought feedback in advisory meetings and a ...
Adults with type 1 diabetes who continued or transitioned to the Omnipod 5 Automated Insulin Delivery (AID) System maintained ...
For very many years, being busy wasn't just a schedule; it was a personality trait. The ideal worker was available, ...
Kakao Healthcare will lend Dexcom G7 glucose monitoring receivers free of charge to type 1 diabetes students taking Korea's ...
DexCom has underperformed the broader market over the past year, while analysts remain strongly optimistic about its future prospects.
DexCom, Inc. announced the appointment of Glenn Boehnlein to its Board of Directors, effective September 10, 2026. Mr. Boehnlein is a highly accomplished healthcare executive and finance leader with ...
Tandem Diabetes Care has strong insulin-pump tech, but ongoing losses and cash burn threaten viability. Click here to read ...
Oura's S-1 reports 74% revenue growth, 5 million paid members and a $16bn valuation target, alongside a lawsuit challenging ...
Global Wireless Medical Technologies Market was valued at USD 51.20 Billion in 2025 and is expected to grow at 11.50% CAGR to reach USD 151.80 Billion by 2035.